On this page
MTTP
microsomal triglyceride transfer protein
The MTTP gene provides instructions for making microsomal triglyceride transfer protein, which is essential for the production of beta-lipoproteins that transport fats and vitamins throughout the body. The MTTP gene encodes a protein crucial for the formation of beta-lipoproteins, which are responsible for carrying dietary fats, cholesterol, and fat-soluble vitamins.
MTTP is located on the long (q) arm of chromosome 4, at band 4q23. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 4 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The MTTP gene provides the genetic blueprint for microsomal triglyceride transfer protein (MTP). This protein plays a fundamental role in the body's ability to absorb and transport dietary fats and fat-soluble vitamins.
Functioning primarily within the digestive system and liver, MTP is indispensable for the formation of lipoproteins, which are crucial for nutrient distribution. Variations in the MTTP gene can lead to impaired fat metabolism, impacting various bodily systems.
What the gene does
The microsomal triglyceride transfer protein (MTP), encoded by the MTTP gene, is critical for assembling beta-lipoproteins. These complex molecules are composed of proteins, cholesterol, phospholipids, and triglycerides. In the intestine, MTP facilitates the formation of chylomicrons, which transport dietary fats and cholesterol from digested food into the bloodstream and are necessary for the absorption of fat-soluble vitamins like A, E, and K.
In the liver, MTP is involved in the production of very low-density lipoproteins (VLDL) and low-density lipoproteins (LDL). These lipoproteins are responsible for distributing fats, cholesterol, and fat-soluble vitamins from the liver to tissues throughout the body. Adequate levels of these lipids and vitamins are vital for normal cellular function, growth, and tissue maintenance.
Video: Genetics 101
Chromosome location
The MTTP gene is located on chromosome 4, specifically at position 4q23. This designation refers to the long (q) arm of chromosome 4, in region 2, band 3. The precise location of a gene helps in understanding its genetic neighbourhood and potential regulatory elements.
Protein structure
The microsomal triglyceride transfer protein (MTP) is composed of 894 amino acids. A key structural feature of the MTP protein is the Vitellogenin domain, spanning amino acids 28 to 659. This domain is integral to the protein's function in lipid binding and transfer, which is essential for assembling lipoprotein particles.
Key variants
Genetic variations within the MTTP gene can affect the function of the microsomal triglyceride transfer protein. These variants can range from single nucleotide changes to larger alterations, potentially leading to a protein with reduced activity or one that is non-functional. The impact of such variants depends on their specific nature and location within the gene.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1026_1030dup | p.Ile344fs | Pathogenic | ★★☆☆ | not provided |
c.1197del | p.Phe399fs | Pathogenic/Likely pathogenic | ★★☆☆ | Abetalipoproteinaemia |
c.1229_1231delinsT | p.Ala410fs | Pathogenic | ★★☆☆ | Abetalipoproteinaemia |
c.1236+1G>A | - | Pathogenic/Likely pathogenic | ★★☆☆ | MTTP-related disorder |
c.1769+2T>C | - | Pathogenic/Likely pathogenic | ★★☆☆ | Abetalipoproteinaemia |
c.1820del | p.Arg607fs | Pathogenic | ★★☆☆ | MTTP-related disorder |
c.2031del | p.Thr678fs | Pathogenic/Likely pathogenic | ★★☆☆ | Abetalipoproteinaemia |
c.2228T>A | p.Leu743Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Abetalipoproteinaemia |
c.2230C>T | p.Gln744Ter | Pathogenic | ★★☆☆ | Abetalipoproteinaemia |
c.2342+1G>A | - | Pathogenic | ★★☆☆ | Abetalipoproteinaemia |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the MTTP gene are primarily associated with Abetalipoproteinaemia. This is an inherited condition characterised by the body's inability to fully absorb dietary fats and fat-soluble vitamins.
UK clinical status
The MTTP gene is assessed on several UK NHS National Genomic Test Directory panels, indicating its clinical relevance in the UK. It is a 'green' gene on panels for conditions such as Ataxia and cerebellar anomalies - childhood onset, Hereditary ataxia, Hereditary ataxia, adult onset, Hereditary neuropathy, Hereditary neuropathy or pain disorder (R78), Intestinal failure or congenital diarrhoea (R331), Likely inborn error of metabolism (R98), Retinal disorders (R32), and Undiagnosed metabolic disorders.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the MTTP gene?
The MTTP gene provides instructions for making microsomal triglyceride transfer protein, which is essential for assembling beta-lipoproteins. These lipoproteins transport dietary fats, cholesterol, and fat-soluble vitamins from the intestine and liver to various body tissues.
What condition is most commonly associated with MTTP gene variants?
Variants in the MTTP gene are most commonly associated with abetalipoproteinaemia. This condition impairs the body's ability to absorb fats and fat-soluble vitamins, leading to a range of symptoms primarily affecting the gastrointestinal system, eyes, nervous system, and blood.
Where is the MTTP gene located in the human genome?
The MTTP gene is located on chromosome 4. Specifically, it resides on the long arm of chromosome 4 at position 4q23.
References
- Walsh MT, Hussain MM. Targeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia. Critical reviews in clinical laboratory sciences. 2017. PMID: 27690713
- Gündüz M, Özaydın E, Atar MB. Microsomal triglyceride transfer protein gene mutations in Turkish children: A novel mutation and clinical follow up. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology. 2016. PMID: 27160094
- Walsh MT, Di Leo E, Okur I. Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects. Biochimica et biophysica acta. 2016. PMID: 27487388
- Benayoun L, Granot E, Rizel L. Abetalipoproteinemia in Israel: evidence for a founder mutation in the Ashkenazi Jewish population and a contiguous gene deletion in an Arab patient. Molecular genetics and metabolism. 2007. PMID: 17275380
- Swift LL, Kakkad B, Boone C. Microsomal triglyceride transfer protein expression in adipocytes: a new component in fat metabolism. FEBS letters. 2005. PMID: 15922333
- Hooper AJ, van Bockxmeer FM, Burnett JR. Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism. Critical reviews in clinical laboratory sciences. 2005. PMID: 16390683
- Hussain MM, Iqbal J, Anwar K. Microsomal triglyceride transfer protein: a multifunctional protein. Frontiers in bioscience : a journal and virtual library. 2003. PMID: 12700048